The main mission of UMR_S1140 is to develop new therapeutic strategies in haemostasis and cardiovascular diseases through deep knowledge in the field of molecular mechanisms of haemostasis and vasculogenesis, and of management of antithrombotic drugs to notably decrease drug-related adverse events, with strong clinical application potential.
By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy. At any time you can delete the cookies stored on your browsers.